Current and new strategies in immunotherapy for superficial bladder cancer.
Perabo
Frank G E
FG
Department of Urology, University Hospital, Bonn, Germany.
Müller
Stefan C
SC
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D000283:Administration, Intravesical; D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D003596:Cytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005098:Exotoxins / Q000008:administration & dosage / Q000627:therapeutic use; D006331:Heart Diseases / Q000139:chemically induced; D006433:Hemocyanins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D007378:Interleukins / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D016211:Transforming Growth Factor alpha / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D001428:Bacterial Vaccines; D005098:Exotoxins; D007155:Immunologic Factors; D007378:Interleukins; D011994:Recombinant Proteins; D016211:Transforming Growth Factor alpha; D014409:Tumor Necrosis Factor-alpha; C499107:rubratin; C083452:transforming growth factor alpha-Pseudomonas exotoxin A (40); D003596:Cytosine; D007372:Interferons; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin; C033560:bropirimine